ORG-25935 explained

ORG-25935, also known as SCH-900435 is a synthetic drug developed by Organon International, which acts as a selective inhibitor of the glycine transporter GlyT-1. In animal tests it reduces alcohol consumption and has analgesic and anticonvulsant effects, but it has mainly been studied for its antipsychotic properties, and in human trials it was shown to effectively counteract the effects of the dissociative drug ketamine.[1] [2] [3] [4] [5] [6] [7] [8]

See also

Notes and References

  1. Molander A, Lidö HH, Löf E, Ericson M, Söderpalm B . The glycine reuptake inhibitor Org 25935 decreases ethanol intake and preference in male wistar rats . Alcohol and Alcoholism . 42 . 1 . 11–8 . 17098748 . 10.1093/alcalc/agl085 . 2006 . free .
  2. Morita K, Motoyama N, Kitayama T, Morioka N, Dohi T . Antinociceptive effects of glycine transporter inhibitors in neuropathic pain models in mice . Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica . 130 . 6 . 458–63 . December 2007 . 18079595 . 10.1254/fpj.130.458 . free .
  3. Lidö HH, Stomberg R, Fagerberg A, Ericson M, Söderpalm B . The glycine reuptake inhibitor org 25935 interacts with basal and ethanol-induced dopamine release in rat nucleus accumbens . Alcoholism: Clinical and Experimental Research . 33 . 7 . 1151–7 . July 2009 . 19389199 . 10.1111/j.1530-0277.2009.00938.x .
  4. Kalinichev M, Starr KR, Teague S, Bradford AM, Porter RA, Herdon HJ . Glycine transporter 1 (GlyT1) inhibitors exhibit anticonvulsant properties in the rat maximal electroshock threshold (MEST) test . Brain Research . 1331 . 105–13 . May 2010 . 20303337 . 10.1016/j.brainres.2010.03.032 . 5389997 .
  5. Vengeliene V, Leonardi-Essmann F, Sommer WH, Marston HM, Spanagel R . Glycine transporter-1 blockade leads to persistently reduced relapse-like alcohol drinking in rats . Biological Psychiatry . 68 . 8 . 704–11 . October 2010 . 20655511 . 10.1016/j.biopsych.2010.05.029 . 11014437 .
  6. Musante V, Summa M, Cunha RA, Raiteri M, Pittaluga A . Pre-synaptic glycine GlyT1 transporter--NMDA receptor interaction: relevance to NMDA autoreceptor activation in the presence of Mg2+ ions . Journal of Neurochemistry . 117 . 3 . 516–27 . May 2011 . 21348870 . 10.1111/j.1471-4159.2011.07223.x . 25752716 .
  7. Jardemark K, Marcus MM, Malmerfelt A, Shahid M, Svensson TH . Differential effects of AMPA receptor potentiators and glycine reuptake inhibitors on antipsychotic efficacy and prefrontal glutamatergic transmission . Psychopharmacology . 221 . 1 . 115–31 . May 2012 . 22068461 . 10.1007/s00213-011-2554-3 . 18335206 .
  8. D'Souza DC, Singh N, Elander J, Carbuto M, Pittman B, Udo de Haes J, Sjogren M, Peeters P, Ranganathan M, Schipper J . 6 . Glycine transporter inhibitor attenuates the psychotomimetic effects of ketamine in healthy males: preliminary evidence . Neuropsychopharmacology . 37 . 4 . 1036–46 . March 2012 . 22113087 . 3280648 . 10.1038/npp.2011.295 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "ORG-25935".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.